Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 923

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 3
Chunk 923
---
629 224,550 Basic net loss per share$(1.13)$(1.21)$(1.40)DilutedWeighted-average shares used in computing basic net loss per share274,488253,629224,550Add: Weighted average shares issuable upon conversion of convertible notes (2028 Notes)9,395——Add: Weighted average shares issuable upon conversion of convertible notes (2029 Notes)4,483——Weighted-average shares used in computing diluted net loss per share288,366253,629224,550Diluted net loss per share$(1.59)$(1.21)$(1.40)

Fiscal 2024 Form 10-K122

The following shares issuable upon conversion of the convertible senior notes and outstanding equity awards were excluded from the computation of diluted net loss per share for the periods presented because the effect of including such shares would have been antidilutive:Years Ended December 31,(in thousands)202420232022Shares issuable upon conversion of convertible senior notes20,51231,06320,690Equity awards34,13627,24627,291See Note 2. Business Acquisitions, for detailed information on contingently issuable shares that would be due upon achievement of a milestone. See Note 9. Stockholders’ Equity for detailed information on equity awards.

NOTE 11.  SEGMENT AND GEOGRAPHIC INFORMATIONWe are organized as, and operate in, one reportable segment: the development, manufacturing, and marketing of integrated platforms for genetic analysis. Our chief operating decision-maker (CODM) is our Chief Executive Officer. Our CODM reviews financial information presented on a consolidated basis for the purposes of evaluating financial performance and allocating resources.On a regular basis, our CODM reviews:•total revenues by category•total expenses and expenses by function, including sales and marketing and general and administrative, which include depreciation and share-based compensation•net loss per shareOur assets are primarily located in the United States of America and not allocated to any specific region, and we do not measure the performance of geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue.

Fiscal 2024 Form 10-K123

A summary of the segment profit or loss, including significant segment expenses is as follows:Years Ended December 31,(in thousands)202420232022Total revenue154,014 200,521 128,304 Less:Cost of revenue116,732 147,741